Literature DB >> 20957813

[Laryngeal function as node metastasis predictor in patients with cancer of the larynx].

José Francisco Gallegos1, Armando Fuentes, César Arroyo, Gabriel Minauro, Martín Hernández, Héctor Arias.   

Abstract

INTRODUCTION: Although the possibility of developing cervical node metastases (CNM) in patients with squamous cell carcinoma of the larynx (SCCL) depends on the site of tumor origin, other factors may be associated, even in glottic tumors. The objective of this study was to determine factors associated with CNM.
METHODS: We carried out a retrospective analysis of a series of patients with SCCL. We analyzed the following variables: T-staging, tumor site, and arytenoid-mobility/fixation. and correlated them with histopathological node status. Statistical significance was assessed using chi2 tests.
RESULTS: 91 patients were included 82 were male and 9 female; median age was 66 years. The most frequently affected site was the glottic-subglottic region (38) followed by the glottis (22). The most frequent T stage was T3 (46%) followed by T4 (25%); 81% were NO and 19% N+. 76 (83%) had arytenoid fixation. Factors associated with CNM included glottic-supraglottic infiltration (65%) and arytenoid fixation (17% vs. 0, p = 0.048). None of the patients with arytenoid mobility had CNM. Tumor infiltration to thyroid gland was observed among 14% of patients studied The most important risk factor was subglottic extension (17%; p = 0.5).
CONCLUSIONS: Lack of mobility of the arytenoid cartilage is a factor associated with CNM among SCCL patients. A subglottic tumor is a risk factor for thyroid infiltration

Entities:  

Mesh:

Year:  2010        PMID: 20957813

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  1 in total

1.  Leptomeningeal metastasis from early glottic laryngeal cancer: A case report.

Authors:  Zhenyu Pan; Guozi Yang; Limei Qu; Tingting Yuan; Xiaochuan Pang; Yongxiang Wang; Weiyan Shi; Lihua Dong
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.